What is the current valuation of the Surrogacy Market as of 2024?

The Surrogacy Market was valued at 17.47 USD Billion in 2024. Read More

What is the projected market size for the Surrogacy Market by 2035?

The Surrogacy Market is projected to reach 54.62 USD Billion by 2035. Read More

What is the expected CAGR for the Surrogacy Market during the forecast period 2025 - 2035?

The expected CAGR for the Surrogacy Market during the forecast period 2025 - 2035 is 10.92%. Read More

Which segments of intended parents are contributing to the market growth?

The segments of intended parents include Infertile Couples, Single Individuals, and LGBTQ+ Couples, with valuations of 8.73, 4.18, and 4.56 USD Billion respectively in 2024. Read More

How do the types of surrogacy impact market valuation?

Gestational Surrogacy, valued at 13.98 USD Billion in 2024, significantly outpaces Traditional Surrogacy, which was valued at 3.49 USD Billion. Read More

What are the compensation types in the Surrogacy Market?

The market includes Altruistic Surrogacy, valued at 5.24 USD Billion, and Commercial Surrogacy, which reached 12.23 USD Billion in 2024. Read More

What are the different arrangements available in the Surrogacy Market?

Independent Surrogacy was valued at 7.5 USD Billion, while Agency-Assisted Surrogacy reached 9.97 USD Billion in 2024. Read More

How does the legal framework affect the Surrogacy Market?

Permissive/Legalized Surrogacy, valued at 12.23 USD Billion in 2024, is likely to drive market growth compared to Restrictive/Prohibited Surrogacy at 5.24 USD Billion. Read More

Who are the key players in the Surrogacy Market?

Key players include Circle Surrogacy, Growing Generations, and New Hope Fertility Center, among others. Read More

What trends are expected in the Surrogacy Market by 2035?

The Surrogacy Market is likely to expand significantly, driven by increasing acceptance and demand from diverse intended parent segments. Read More

Surrogacy Market

ID: MRFR/HC/21153-HCR

128 Pages

Satyendra Maurya

Last Updated: April 06, 2026

Surrogacy Market Research Report By Intended Parent Type (Infertile Couples, Single Individuals, LGBTQ+ Couples), By Surrogacy Type (Traditional Surrogacy, Gestational Surrogacy), By Compensation Type (Altruistic Surrogacy, Commercial Surrogacy), By Surrogacy Arrangement (Independent Surrogacy, Agency-Assisted Surrogacy), By Legal Framework (Permissive/Legalized Surrogacy, Restrictive/Prohibited Surrogacy) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Intended Parent Type (USD Billion) | |
  1. 4.1.1 Infertile Couples | |
  2. 4.1.2 Single Individuals | |
  3. 4.1.3 LGBTQ+ Couples |
2. 4.2 Healthcare, BY Surrogacy Type (USD Billion) | |
  1. 4.2.1 Traditional Surrogacy | |
  2. 4.2.2 Gestational Surrogacy |
3. 4.3 Healthcare, BY Compensation Type (USD Billion) | |
  1. 4.3.1 Altruistic Surrogacy | |
  2. 4.3.2 Commercial Surrogacy |
4. 4.4 Healthcare, BY Surrogacy Arrangement (USD Billion) | |
  1. 4.4.1 Independent Surrogacy | |
  2. 4.4.2 Agency-Assisted Surrogacy |
5. 4.5 Healthcare, BY Legal Framework (USD Billion) | |
  1. 4.5.1 Permissive/Legalized Surrogacy | |
  2. 4.5.2 Restrictive/Prohibited Surrogacy |
6. 4.6 Healthcare, BY Region (USD Billion) | |
  1. 4.6.1 North America | | |
    1. 4.6.1.1 US | | |
    2. 4.6.1.2 Canada | |
  2. 4.6.2 Europe | | |
    1. 4.6.2.1 Germany | | |
    2. 4.6.2.2 UK | | |
    3. 4.6.2.3 France | | |
    4. 4.6.2.4 Russia | | |
    5. 4.6.2.5 Italy | | |
    6. 4.6.2.6 Spain | | |
    7. 4.6.2.7 Rest of Europe | |
  3. 4.6.3 APAC | | |
    1. 4.6.3.1 China | | |
    2. 4.6.3.2 India | | |
    3. 4.6.3.3 Japan | | |
    4. 4.6.3.4 South Korea | | |
    5. 4.6.3.5 Malaysia | | |
    6. 4.6.3.6 Thailand | | |
    7. 4.6.3.7 Indonesia | | |
    8. 4.6.3.8 Rest of APAC | |
  4. 4.6.4 South America | | |
    1. 4.6.4.1 Brazil | | |
    2. 4.6.4.2 Mexico | | |
    3. 4.6.4.3 Argentina | | |
    4. 4.6.4.4 Rest of South America | |
  5. 4.6.5 MEA | | |
    1. 4.6.5.1 GCC Countries | | |
    2. 4.6.5.2 South Africa | | |
    3. 4.6.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Circle Surrogacy (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Growing Generations (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Surrogacy Agency (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 The Surrogacy Experience (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Family Source Consultants (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 New Hope Fertility Center (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Surrogacy Center (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 IVF Surrogacy (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY INTENDED PARENT TYPE |
7. 6.4 US MARKET ANALYSIS BY SURROGACY TYPE |
8. 6.5 US MARKET ANALYSIS BY COMPENSATION TYPE |
9. 6.6 US MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
10. 6.7 US MARKET ANALYSIS BY LEGAL FRAMEWORK |
11. 6.8 CANADA MARKET ANALYSIS BY INTENDED PARENT TYPE |
12. 6.9 CANADA MARKET ANALYSIS BY SURROGACY TYPE |
13. 6.10 CANADA MARKET ANALYSIS BY COMPENSATION TYPE |
14. 6.11 CANADA MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
15. 6.12 CANADA MARKET ANALYSIS BY LEGAL FRAMEWORK |
16. 6.13 EUROPE MARKET ANALYSIS |
17. 6.14 GERMANY MARKET ANALYSIS BY INTENDED PARENT TYPE |
18. 6.15 GERMANY MARKET ANALYSIS BY SURROGACY TYPE |
19. 6.16 GERMANY MARKET ANALYSIS BY COMPENSATION TYPE |
20. 6.17 GERMANY MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
21. 6.18 GERMANY MARKET ANALYSIS BY LEGAL FRAMEWORK |
22. 6.19 UK MARKET ANALYSIS BY INTENDED PARENT TYPE |
23. 6.20 UK MARKET ANALYSIS BY SURROGACY TYPE |
24. 6.21 UK MARKET ANALYSIS BY COMPENSATION TYPE |
25. 6.22 UK MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
26. 6.23 UK MARKET ANALYSIS BY LEGAL FRAMEWORK |
27. 6.24 FRANCE MARKET ANALYSIS BY INTENDED PARENT TYPE |
28. 6.25 FRANCE MARKET ANALYSIS BY SURROGACY TYPE |
29. 6.26 FRANCE MARKET ANALYSIS BY COMPENSATION TYPE |
30. 6.27 FRANCE MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
31. 6.28 FRANCE MARKET ANALYSIS BY LEGAL FRAMEWORK |
32. 6.29 RUSSIA MARKET ANALYSIS BY INTENDED PARENT TYPE |
33. 6.30 RUSSIA MARKET ANALYSIS BY SURROGACY TYPE |
34. 6.31 RUSSIA MARKET ANALYSIS BY COMPENSATION TYPE |
35. 6.32 RUSSIA MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
36. 6.33 RUSSIA MARKET ANALYSIS BY LEGAL FRAMEWORK |
37. 6.34 ITALY MARKET ANALYSIS BY INTENDED PARENT TYPE |
38. 6.35 ITALY MARKET ANALYSIS BY SURROGACY TYPE |
39. 6.36 ITALY MARKET ANALYSIS BY COMPENSATION TYPE |
40. 6.37 ITALY MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
41. 6.38 ITALY MARKET ANALYSIS BY LEGAL FRAMEWORK |
42. 6.39 SPAIN MARKET ANALYSIS BY INTENDED PARENT TYPE |
43. 6.40 SPAIN MARKET ANALYSIS BY SURROGACY TYPE |
44. 6.41 SPAIN MARKET ANALYSIS BY COMPENSATION TYPE |
45. 6.42 SPAIN MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
46. 6.43 SPAIN MARKET ANALYSIS BY LEGAL FRAMEWORK |
47. 6.44 REST OF EUROPE MARKET ANALYSIS BY INTENDED PARENT TYPE |
48. 6.45 REST OF EUROPE MARKET ANALYSIS BY SURROGACY TYPE |
49. 6.46 REST OF EUROPE MARKET ANALYSIS BY COMPENSATION TYPE |
50. 6.47 REST OF EUROPE MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
51. 6.48 REST OF EUROPE MARKET ANALYSIS BY LEGAL FRAMEWORK |
52. 6.49 APAC MARKET ANALYSIS |
53. 6.50 CHINA MARKET ANALYSIS BY INTENDED PARENT TYPE |
54. 6.51 CHINA MARKET ANALYSIS BY SURROGACY TYPE |
55. 6.52 CHINA MARKET ANALYSIS BY COMPENSATION TYPE |
56. 6.53 CHINA MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
57. 6.54 CHINA MARKET ANALYSIS BY LEGAL FRAMEWORK |
58. 6.55 INDIA MARKET ANALYSIS BY INTENDED PARENT TYPE |
59. 6.56 INDIA MARKET ANALYSIS BY SURROGACY TYPE |
60. 6.57 INDIA MARKET ANALYSIS BY COMPENSATION TYPE |
61. 6.58 INDIA MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
62. 6.59 INDIA MARKET ANALYSIS BY LEGAL FRAMEWORK |
63. 6.60 JAPAN MARKET ANALYSIS BY INTENDED PARENT TYPE |
64. 6.61 JAPAN MARKET ANALYSIS BY SURROGACY TYPE |
65. 6.62 JAPAN MARKET ANALYSIS BY COMPENSATION TYPE |
66. 6.63 JAPAN MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
67. 6.64 JAPAN MARKET ANALYSIS BY LEGAL FRAMEWORK |
68. 6.65 SOUTH KOREA MARKET ANALYSIS BY INTENDED PARENT TYPE |
69. 6.66 SOUTH KOREA MARKET ANALYSIS BY SURROGACY TYPE |
70. 6.67 SOUTH KOREA MARKET ANALYSIS BY COMPENSATION TYPE |
71. 6.68 SOUTH KOREA MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
72. 6.69 SOUTH KOREA MARKET ANALYSIS BY LEGAL FRAMEWORK |
73. 6.70 MALAYSIA MARKET ANALYSIS BY INTENDED PARENT TYPE |
74. 6.71 MALAYSIA MARKET ANALYSIS BY SURROGACY TYPE |
75. 6.72 MALAYSIA MARKET ANALYSIS BY COMPENSATION TYPE |
76. 6.73 MALAYSIA MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
77. 6.74 MALAYSIA MARKET ANALYSIS BY LEGAL FRAMEWORK |
78. 6.75 THAILAND MARKET ANALYSIS BY INTENDED PARENT TYPE |
79. 6.76 THAILAND MARKET ANALYSIS BY SURROGACY TYPE |
80. 6.77 THAILAND MARKET ANALYSIS BY COMPENSATION TYPE |
81. 6.78 THAILAND MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
82. 6.79 THAILAND MARKET ANALYSIS BY LEGAL FRAMEWORK |
83. 6.80 INDONESIA MARKET ANALYSIS BY INTENDED PARENT TYPE |
84. 6.81 INDONESIA MARKET ANALYSIS BY SURROGACY TYPE |
85. 6.82 INDONESIA MARKET ANALYSIS BY COMPENSATION TYPE |
86. 6.83 INDONESIA MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
87. 6.84 INDONESIA MARKET ANALYSIS BY LEGAL FRAMEWORK |
88. 6.85 REST OF APAC MARKET ANALYSIS BY INTENDED PARENT TYPE |
89. 6.86 REST OF APAC MARKET ANALYSIS BY SURROGACY TYPE |
90. 6.87 REST OF APAC MARKET ANALYSIS BY COMPENSATION TYPE |
91. 6.88 REST OF APAC MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
92. 6.89 REST OF APAC MARKET ANALYSIS BY LEGAL FRAMEWORK |
93. 6.90 SOUTH AMERICA MARKET ANALYSIS |
94. 6.91 BRAZIL MARKET ANALYSIS BY INTENDED PARENT TYPE |
95. 6.92 BRAZIL MARKET ANALYSIS BY SURROGACY TYPE |
96. 6.93 BRAZIL MARKET ANALYSIS BY COMPENSATION TYPE |
97. 6.94 BRAZIL MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
98. 6.95 BRAZIL MARKET ANALYSIS BY LEGAL FRAMEWORK |
99. 6.96 MEXICO MARKET ANALYSIS BY INTENDED PARENT TYPE |
100. 6.97 MEXICO MARKET ANALYSIS BY SURROGACY TYPE |
101. 6.98 MEXICO MARKET ANALYSIS BY COMPENSATION TYPE |
102. 6.99 MEXICO MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
103. 6.100 MEXICO MARKET ANALYSIS BY LEGAL FRAMEWORK |
104. 6.101 ARGENTINA MARKET ANALYSIS BY INTENDED PARENT TYPE |
105. 6.102 ARGENTINA MARKET ANALYSIS BY SURROGACY TYPE |
106. 6.103 ARGENTINA MARKET ANALYSIS BY COMPENSATION TYPE |
107. 6.104 ARGENTINA MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
108. 6.105 ARGENTINA MARKET ANALYSIS BY LEGAL FRAMEWORK |
109. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY INTENDED PARENT TYPE |
110. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY SURROGACY TYPE |
111. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY COMPENSATION TYPE |
112. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
113. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY LEGAL FRAMEWORK |
114. 6.111 MEA MARKET ANALYSIS |
115. 6.112 GCC COUNTRIES MARKET ANALYSIS BY INTENDED PARENT TYPE |
116. 6.113 GCC COUNTRIES MARKET ANALYSIS BY SURROGACY TYPE |
117. 6.114 GCC COUNTRIES MARKET ANALYSIS BY COMPENSATION TYPE |
118. 6.115 GCC COUNTRIES MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
119. 6.116 GCC COUNTRIES MARKET ANALYSIS BY LEGAL FRAMEWORK |
120. 6.117 SOUTH AFRICA MARKET ANALYSIS BY INTENDED PARENT TYPE |
121. 6.118 SOUTH AFRICA MARKET ANALYSIS BY SURROGACY TYPE |
122. 6.119 SOUTH AFRICA MARKET ANALYSIS BY COMPENSATION TYPE |
123. 6.120 SOUTH AFRICA MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
124. 6.121 SOUTH AFRICA MARKET ANALYSIS BY LEGAL FRAMEWORK |
125. 6.122 REST OF MEA MARKET ANALYSIS BY INTENDED PARENT TYPE |
126. 6.123 REST OF MEA MARKET ANALYSIS BY SURROGACY TYPE |
127. 6.124 REST OF MEA MARKET ANALYSIS BY COMPENSATION TYPE |
128. 6.125 REST OF MEA MARKET ANALYSIS BY SURROGACY ARRANGEMENT |
129. 6.126 REST OF MEA MARKET ANALYSIS BY LEGAL FRAMEWORK |
130. 6.127 KEY BUYING CRITERIA OF HEALTHCARE |
131. 6.128 RESEARCH PROCESS OF MRFR |
132. 6.129 DRO ANALYSIS OF HEALTHCARE |
133. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
134. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
135. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE |
136. 6.133 HEALTHCARE, BY INTENDED PARENT TYPE, 2024 (% SHARE) |
137. 6.134 HEALTHCARE, BY INTENDED PARENT TYPE, 2024 TO 2035 (USD Billion) |
138. 6.135 HEALTHCARE, BY SURROGACY TYPE, 2024 (% SHARE) |
139. 6.136 HEALTHCARE, BY SURROGACY TYPE, 2024 TO 2035 (USD Billion) |
140. 6.137 HEALTHCARE, BY COMPENSATION TYPE, 2024 (% SHARE) |
141. 6.138 HEALTHCARE, BY COMPENSATION TYPE, 2024 TO 2035 (USD Billion) |
142. 6.139 HEALTHCARE, BY SURROGACY ARRANGEMENT, 2024 (% SHARE) |
143. 6.140 HEALTHCARE, BY SURROGACY ARRANGEMENT, 2024 TO 2035 (USD Billion) |
144. 6.141 HEALTHCARE, BY LEGAL FRAMEWORK, 2024 (% SHARE) |
145. 6.142 HEALTHCARE, BY LEGAL FRAMEWORK, 2024 TO 2035 (USD Billion) |
146. 6.143 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
147. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
148. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.2.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
149. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.3.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
150. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.4.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
151. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.5.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
152. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.6.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
153. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.7.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
154. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.8.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
155. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.9.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
156. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.10.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
157. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.11.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
158. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.12.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
159. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.13.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
160. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.14.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
161. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.15.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
162. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.16.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
163. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.17.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
164. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.18.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
165. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.19.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
166. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.20.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
167. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.21.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
168. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.22.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
169. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.23.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
170. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.24.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
171. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.25.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
172. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.26.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
173. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.27.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
174. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.28.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
175. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.29.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
176. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY INTENDED PARENT TYPE, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY SURROGACY TYPE, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY COMPENSATION TYPE, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY SURROGACY ARRANGEMENT, 2025-2035 (USD Billion) | |
  5. 7.30.5 BY LEGAL FRAMEWORK, 2025-2035 (USD Billion) |
177. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
178. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Intended Parent Type (USD Billion, 2025-2035)

Infertile Couples
Single Individuals
LGBTQ+ Couples

Healthcare By Surrogacy Type (USD Billion, 2025-2035)

Traditional Surrogacy
Gestational Surrogacy

Healthcare By Compensation Type (USD Billion, 2025-2035)

Altruistic Surrogacy
Commercial Surrogacy

Healthcare By Surrogacy Arrangement (USD Billion, 2025-2035)

Independent Surrogacy
Agency-Assisted Surrogacy

Healthcare By Legal Framework (USD Billion, 2025-2035)

Permissive/Legalized Surrogacy
Restrictive/Prohibited Surrogacy

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓